Renal Cell Carcinoma
Insights from 2025 ASCO® GU Annual Meeting
ASCO® GU 2025 Insights: Survival of Patients With mRCC With or Without Brain Metastases
FEATURING
Michael Hurwitz
- 28 views
- April 2, 2025
Insights from 2025 ASCO® GU Annual Meeting
ASCO® GU 2025 Insights: Updated Results of the TIDE-A Study Evaluating Avelumab + Intermittent Axitinib in Previously Untreated Patients With mRCC
FEATURING
Chiara Ciccarese
- 22 views
- March 30, 2025
Insights from 2025 ASCO® GU Annual Meeting
ASCO® GU 2025 Summary: Immunogenomic Determinants of Exceptional Response to ICI in RCC - Data From CheckMate 214 and JAVELIN Renal 101
FEATURING
Renee Maria Saliby
- 31 views
- March 19, 2025
Insights from 2025 ASCO® GU Annual Meeting
ASCO® GU 2025 Summary: The Future of Biomarkers in RCC
FEATURING
Samra Turajlic
- 36 views
- March 10, 2025
Insights from 2025 ASCO® GU Annual Meeting
ASCO® GU 2025 Insights: Association Between PD-1 Expression on Regulatory T Cells and Resistance to 1L Nivo in Advanced ccRCC - HCRN GU16-260 Trial
FEATURING
Razan Mohanna
- 7 views
- March 7, 2025
Insights from 2025 ASCO® GU Annual Meeting
ASCO® GU 2025 Insights: Efficacy Outcomes With Belzutifan vs. Everolimus by Baseline Disease Characteristics and Burden Subgroups - LITESPARK-005 Study
FEATURING
Guillermo de Velasco
- 36 views
- March 4, 2025
Insights from 2025 ASCO® GU Annual Meeting
ASCO® GU 2025 Summary: Striving Toward New Frontiers in Clear Cell Kidney Cancer - Insights From Key Trials
FEATURING
Tian Zhang
- 113 views
- March 4, 2025
Insights from 2025 ASCO® GU Annual Meeting
ASCO® GU 2025 Insights: Optimizing Immunotherapy Strategies With Evolocumab and Nivolumab in mRCC - BOOST-RCC Study
FEATURING
Tian Zhang
- 13 views
- March 4, 2025
Insights from 2025 ASCO® GU Annual Meeting
ASCO® GU 2025 Insights: Final OS and ctDNA Data for Savolitinib + Durvalumab in Advanced Papillary Renal Cancer - CALYPSO Trial
FEATURING
Francesca Jackson-Spence
- 11 views
- February 27, 2025
Insights from 2025 ASCO® GU Annual Meeting
ASCO® GU 2025 Summary: Biomarkers in RCC - Current State and Future Potential
FEATURING
Simpa Salami
- 145 views
- February 26, 2025
Insights from 2025 ASCO® GU Annual Meeting
ASCO® GU 2025 Insights: Efficacy and Safety of Nivo/Ipi in Metastatic Variant Histology RCC - A Retrospective Analysis From MD Anderson
FEATURING
Mohammad Jad Moussa
- 78 views
- February 25, 2025
- 2
Insights from 2025 ASCO® GU Annual Meeting
ASCO® GU 2025 Summary: Adjuvant Therapy in RCC - A Practical Guide
FEATURING
Laurence Albiges
- 79 views
- February 24, 2025
- 2
Insights from 2025 ASCO® GU Annual Meeting
ASCO® GU 2025 Insights: Cytoreductive Nephrectomy in mRCC - Perioperative Risk Characteristics in the Contemporary Era
FEATURING
Shawn Dason
- 19 views
- February 21, 2025
Insights from 2025 ASCO® GU Annual Meeting
ASCO® GU 2025 Insights: Cabozantinib + Nivo + Ipi in 1L aRCC - Final Results of COSMIC-313
FEATURING
Laurence Albiges
- 63 views
- February 20, 2025
- 2